BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11370617)

  • 1. Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas.
    Evans DB
    J Gastrointest Surg; 2001; 5(1):2-5. PubMed ID: 11370617
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
    Evans DB; Varadhachary GR; Crane CH; Sun CC; Lee JE; Pisters PW; Vauthey JN; Wang H; Cleary KR; Staerkel GA; Charnsangavej C; Lano EA; Ho L; Lenzi R; Abbruzzese JL; Wolff RA
    J Clin Oncol; 2008 Jul; 26(21):3496-502. PubMed ID: 18640930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas.
    Mehta VK; Fisher G; Ford JA; Poen JC; Vierra MA; Oberhelman H; Niederhuber J; Bastidas JA
    J Gastrointest Surg; 2001; 5(1):27-35. PubMed ID: 11309645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.
    Breslin TM; Janjan NA; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Evans DB
    Front Biosci; 1998 Nov; 3():E193-203. PubMed ID: 9792895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.
    Berardi R; Verdecchia L; Scartozzi M; Cascinu S
    JOP; 2005 Jan; 6(1 Suppl):118-21. PubMed ID: 15650296
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
    Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
    Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.
    Evans DB; Rich TA; Byrd DR; Cleary KR; Connelly JH; Levin B; Charnsangavej C; Fenoglio CJ; Ames FC
    Arch Surg; 1992 Nov; 127(11):1335-9. PubMed ID: 1359851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Neoadjuvant Therapy in Pancreatic Cancer Increase the Pool of Patients Eligible for Pancreaticoduodenectomy?
    Hackert T; Ulrich A; Büchler MW
    Adv Surg; 2017 Sep; 51(1):1-10. PubMed ID: 28797331
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Rationale and technique.
    Evans DB; Byrd DR; Mansfield PF
    Am J Clin Oncol; 1991 Aug; 14(4):359-64. PubMed ID: 1862769
    [No Abstract]   [Full Text] [Related]  

  • 11. Pancreatic adenocarcinoma.
    Eskander MF; Bliss LA; Tseng JF
    Curr Probl Surg; 2016 Mar; 53(3):107-54. PubMed ID: 26923296
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival.
    Barbier L; Turrini O; Grégoire E; Viret F; Le Treut YP; Delpero JR
    HPB (Oxford); 2011 Jan; 13(1):64-9. PubMed ID: 21159106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
    White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D
    Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
    Meszoely IM; Wang H; Hoffman JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Prolonged Time to Pancreaticoduodenectomy After Neoadjuvant Chemoradiation.
    Teng A; Nguyen T; Bilchik AJ; O'Connor V; Lee DY
    J Surg Res; 2020 Jan; 245():51-56. PubMed ID: 31401247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
    Turrini O; Ychou M; Moureau-Zabotto L; Rouanet P; Giovannini M; Moutardier V; Azria D; Delpero JR; Viret F
    Eur J Surg Oncol; 2010 Oct; 36(10):987-92. PubMed ID: 20828979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant treatment of pancreatic cancer].
    Michalski CW; Kleeff J; Jäger D; Friess H; Büchler MW
    Dtsch Med Wochenschr; 2007 Apr; 132(15):803-7. PubMed ID: 17427090
    [No Abstract]   [Full Text] [Related]  

  • 18. Multimodality management of localized pancreatic cancer.
    Wayne JD; Wolff RA; Pisters PW; Evans DB
    Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
    Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
    Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer.
    Kim YE; Park MS; Hong HS; Kang CM; Choi JY; Lim JS; Lee WJ; Kim MJ; Kim KW
    Radiology; 2009 Mar; 250(3):758-65. PubMed ID: 19164113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.